Table 2.
Expression pattern of CK19, Glypican-3 (GLP-3), and AFP in testicular tumours
| TF(n = 50) | IGCNU(n = 25) | SEM(n = 67) | EC(n = 56) | YST(n = 29) | CC(n = 2) | LCT(n = 10) | SCT(n = 4) | |
|---|---|---|---|---|---|---|---|---|
| CK19 | 0/50 | 0/25 | 0/67 | 0/56 | 29/29 | 2/2 | 0/10 | 0/4 |
| GLP-3 | 0/50 | 0/25 | 0/67 | 0/56 | 29/29 | 0/2 | 0/10 | 0/4 |
| AFP | 0/50 | 0/25 | 0/67 | 0/56 | 18/29 | 0/2 | n.d | n.d |
(TF = normal testis, IGCNU = intratubular germ cell neoplasia, SEM = seminoma, EC = embryonic carcinoma, YST = yolk sac tumour, TER = teratoma, CC = chorionic carcinoma, LCT = leydig cell tumours, SCT = sertoli cell tumours).